Us Bancorp \De\ Albireo Pharma, Inc. Transaction History

Us Bancorp \De\

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$18.01 - $23.78 $3,962 - $5,231	220 Added 8.98%	2,669 $57,000
Q3 2022 Oct 27, 2022	SELL	$16.32 - $26.37 $2,186 - $3,533	-134 Reduced 5.19%	2,449 $47,000
Q2 2022 Aug 01, 2022	BUY	$18.54 - $37.29 $13,274 - $26,699	716 Added 38.35%	2,583 $51,000
Q1 2022 May 11, 2022	SELL	$23.94 - $33.74 $1,053 - $1,484	-44 Reduced 2.3%	1,867 $56,000
Q3 2021 Nov 10, 2021	SELL	$27.36 - $35.98 $1,778 - $2,338	-65 Reduced 3.29%	1,911 $59,000
Q2 2021 Aug 05, 2021	SELL	$28.9 - $36.87 $1,098 - $1,401	-38 Reduced 1.89%	1,976 $70,000
Q1 2021 Apr 28, 2021	SELL	$32.03 - $42.85 $3,779 - $5,056	-118 Reduced 5.53%	2,014 $71,000
Q4 2020 Feb 04, 2021	BUY	$31.56 - $42.16 $7,164 - $9,570	227 Added 11.92%	2,132 $80,000
Q3 2020 Nov 10, 2020	BUY	$23.19 - $41.61 $41,834 - $75,064	1,804 Added 1786.14%	1,905 $63,000
Q2 2020 Aug 07, 2020	BUY	$14.82 - $29.92 $1,496 - $3,021	101 New	101 $3,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.